Prostate cancer team at Focal Healthcare

“We are committed to improving the lives of prostate cancer patients and their families by producing world-class medical equipment” – Chicuong La, President and CEO

 

 

Board of Directors

Jordan (Zhuoding) Pi

Jordan (Zhuoding) Pi

Director

Click here to learn more

Jordan Pi has more than 20 years of experience as a senior executive in the high-tech industry in China. Jordan joined the Lenovo Group in 1990, and during his five year tenure held several senior management positions. After Lenovo, he was quickly promoted to Country Manager at Lotus Development Company. Under his supervision, revenue at Lotus China increased by 200% in 1996 and by 600% in 1997.

His impressive track record and management skills were noticed by Adobe and he joined the company in 1998. At Adobe he quickly reorganized the China team creating a unique matrix of local sales channels and implementing sales strategies that incorporated China’s distinct business culture.  Under Jordan’s leadership, Adobe’s brand and revenue increased rapidly, and he was promoted to the position of General Manager of Greater China, which includes Hong Kong and Taiwan; Jordan was the first Chinese national to hold the position.

In May 2006, Jordan left Adobe to start a new venture. In partnership with friends, the company they founded became a leader in China for providing third party payment solutions. In May 2009, it was acquired by Lakala.

Over the last several years, Jordan has continued his entrepreneurial passion by advising, mentoring, and providing private equity funding for early stage technology companies.

Jordan holds a BSc and MSc from Peking University.

Chicuong La

Chicuong La

President and Chief Executive Officer

Click here to learn more

Dr. Chicuong La has served as the VP of Business Development and the COO of Imagistx, a prostate imaging company, as well as the Managing Partner of Simulogic, a software company in applied medical research. He also served as Business Development Manager at the Robarts Research Institute, a world-renown medical imaging research center.

His hands on experience in development of medical imaging devices and working with researchers has given him a strong understanding of the technical, logistical, financial and legal needs of Focal Healthcare, Inc..

Chicuong has a PhD in Physiology and Biophysics a Juris Doctor from Dalhousie University.

Sunny Sodhi

Sunny Sodhi

Director

Click here to learn more

Sunny Sodhi is SVP & Chief Legal Officer at Meridian Credit Union, a leading Canadian financial institution. In addition to overseeing legal and regulatory affairs, Sunny is deeply involved in strategy development and government relations for Meridian.

Prior to joining Meridian’s senior executive team, Sunny practiced law in Toronto with Torys LLP and, ultimately, Fasken Martineau DuMoulin LLP as a Partner. He also worked abroad with top international law firm Freshfields Bruckhaus Deringer LLP in Singapore, focusing on cross-border mergers and acquisitions.

Throughout his legal career, Sunny has maintained a practice encompassing a broad range of corporate and commercial law, acquiring deep expertise in M&A, banking, private equity, venture capital, and corporate governance. Since beginning his practice in 2003, Sunny advised on transactions involving over 40 countries, and the purchase, sale or transfer of over $100 billion in assets. He has been involved in some of the largest and most notable cross-border mergers involving Canadian companies.

Sunny has been recognized repeatedly by top international legal rankings as a leading lawyer in Canada for corporate/M&A and banking.

Sunny holds a B.Comm. (Hons) degree from the University of British Columbia, and a Juris Doctor from the University of Victoria. He has been a member of the Bar in Ontario and New York since 2003.

 

 

Clinical Directors

Dr. Winston E. Barzell

Professor at Florida State University College of Medicine

Click here to learn more

Dr. Barzell is a professor at Florida State University College of Medicine and a Urologic Surgeon at 21st Century Oncology. He is a Memorial Sloan-Kettering fellow who has over 40 years of experience in urology. Dr. Barzell is a pioneer in prostate cancer diagnosis and treatment, a prolific inventor and a true entrepreneur. In 2002 he sold his company, Barzell-Whitmore Maroon-Bells Inc., to Civco Medical Solutions. Dr. Barzell holds 18 patents; he has led many clinical trials, and has published extensively in the field of prostate cancer.

Dr. Laurence Klotz

Professor of Surgery at University of Toronto

Click here to learn more

Laurence Klotz, M.D., has been practicing in urology for over 30 years and is the past Chief of Urology at Sunnybrook Health Sciences Centre and Professor of Surgery at the University of Toronto. He is Chairman of the World Uro-Oncology Federation, past president of the Urological Research Society and the Canadian Urological Association.  Dr. Klotz is a widely published uro-oncologist with over 350 publications and 5 books. His main research interest has been prostate cancer.

Dr. Klotz has been honoured numerous times throughout his career.  Recently his work in treating prostate cancer, notably leading the adoption of Active Surveillance, resulted in his being awarded the Order of Canada in 2015. He also received the American Urological Association’s (AUA) Richard Williams Award in 2016 for his outstanding and impactful research in the field of prostate cancer over the last 10 years.

Dr. Daniel J. Margolis

Associate Professor of Radiology at Weill Cornell Medicine

Click here to learn more

Dr. Margolis is the Co-Director, Prostate Magnetic Resonance Imaging and Associate Clinical Professor at the David Geffen School of Medicine at UCLA. Dr. Margolis is in charge of virtual colonography at UCLA. He is interested in the use of MRI for characterization of cancer and efficacy of treatment. Dr. Margolis is a world renowned expert in using MRI to characterize prostate cancer and has helped develop Fusion MR, the software that is used to trace tumours on the MR images

Dr. Michael S. McGuire

Chief of Urology at NorthShore University Health System

Click here to learn more

Dr. McGuire is the Chief of Urology at NorthShore University Health System. He is a Memorial Sloan-Kettering fellow in Urologic Oncology. He is also a Clinical Assistant Professor at the University of Chicago Pritzker School of Medicine and an Assistant Professor at Northwestern University Feinberg School of Medicine. He is a strong advocate of MRI/TRUS Fusion Targeted biopsy. He also leads one of the largest cohorts of active surveillance patients in the country. Dr. McGuire is an early adopter MRI Fusion biopsy technology and may have more hands on experience with targeted biopsy than any else in the country.